JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 September 2008

J Clin Pathol. Published Online First: 13 June 2008. doi:10.1136/jcp.2008.057794
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Free to AccessThis article has been Unlocked
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
jcp.2008.057794v1
61/9/1038    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Bungo Furusato
David G. McLeod
Google Scholar
Right arrow Articles by Furusato, B.
Right arrow Articles by McLeod, D. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furusato, B.
Right arrow Articles by McLeod, D. G.

Inter-disciplinary

Do patients with low volume prostate cancer have PSA recurrence following radical prostatectomy?

Bungo Furusato 1, Inger L. Rosner 2, David Osborn 2, Amina Ali 3, Shiv Srivastava 3, Charles J. Davis 1, Isabell A. Sesterhenn 1 and David G. McLeod 3*

1 Department of Genitourinary Pathology, Armed Forces Institute of Pathology, Washington, DC, United States
2 Department of Surgery, Urology Service, Walter Reed Army Medical Center, Washington, DC, United States
3 Center for Prostate Disease Research, United States

* To whom correspondence should be addressed. E-mail: dgmcleod{at}verizon.net.

Accepted 15 May 2008


*   Abstract

Aims: The objective of this study is to determine the incidence of PSA relapse in patients with low volume prostate cancer following radical prostatectomy.

Methods: Between 1993 and 2001, 50 of 717 patients had total tumor volumes of less than 0.5 cc following radical prostatectomy. Biochemical recurrence was defined as two consecutive values of serum PSA levels of 0.2 ng/mL or greater.

Results: Median follow-up of the 50 patients was 58 months. In five of the 50 patients (10%), PSA recurrence was observed. All of these five cases had Gleason score of 3+3 (well and /or moderately differentiated), organ confined and surgical margin negative tumors. In three of the five cases, capsular incision resulted in benign glands extending into the surgical margin.

Conclusions: Five of 50 cases had PSA failure. In three of the five patients, benign glands located in the margin could explain the "PSA recurrence". However, in the other two patients, none of the pathological parameters correlated with measurable PSA levels. The explanation for their PSA failure is unclear.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.